• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多数人类急性白血病中存在威尔姆斯瘤基因(wt1)转录本和WT1核蛋白。

Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.

作者信息

Menssen H D, Renkl H J, Rodeck U, Maurer J, Notter M, Schwartz S, Reinhardt R, Thiel E

机构信息

Department of Hematology and Oncology, Benjamin Franklin Klinik, Freie Universität Berlin, Germany.

出版信息

Leukemia. 1995 Jun;9(6):1060-7.

PMID:7596170
Abstract

The wt1 gene is located on chromosome 11p13 and encodes a zinc finger motif-containing transcription factor involved in regulation of growth and differentiation. Its expression was shown during embryonic development in various tissues as well as in a few human malignancies including acute leukemias. Using RT-PCR, we found wt1 gene expression in blast cells of the majority of 150 acute leukemia patients. Particularly, the wt1 transcript was detected in 12 of 14 (86%) pre-pre-B-ALL patients, in 33 of 41 (80%) cALL patients, in 23 of 31 (74%) T-ALL patients, and in 53 of 57 (93%) AML patients. Additionally, mononuclear cells from CML patients expressed the wt1 gene only when diagnosed with blast crisis. In contrast to acute human leukemias, mononuclear cells from reactive bone marrow (n = 4), and peripheral blood of healthy volunteers (n = 20), as well as normal peripheral CD34+ hematopoietic progenitors (n = 6) did not express the wt1 gene at detectable levels. Using the anti-WT1 MoAb 6F-H2 in an immunofluorescence assay on single cell level, we found the translated WT1 protein only in nuclei of leukemia blast cells but not in nuclei of normal CD34+ hematopoietic progenitor cells. Blast cells of 12 of 20 leukemia patients (60%) all tested positive for the wt1 gene expression by RT-PCR displayed a strong nuclear immunofluorescence. Its expression in the majority of human acute leukemias but not in normal mononuclear blood cells and normal CD34+ hematopoietic progenitors qualifies the wt1 gene transcript as a 'pan-acute leukemic' marker probably useful in monitoring minimal residual disease after chemotherapy and in detecting leukemic blast cells in purged or unpurged hematopoietic stem cell preparations intended to be used for autologous bone marrow transplantation.

摘要

wt1基因位于11号染色体p13区,编码一种含锌指基序的转录因子,参与生长和分化的调控。其表达在胚胎发育过程中的各种组织以及包括急性白血病在内的一些人类恶性肿瘤中均有显示。通过逆转录聚合酶链反应(RT-PCR),我们在150例急性白血病患者中的大多数原始细胞中发现了wt1基因表达。特别地,在14例前前B淋巴细胞白血病(pre-pre-B-ALL)患者中的12例(86%)、41例普通型急性淋巴细胞白血病(cALL)患者中的33例(80%)、31例T淋巴细胞白血病(T-ALL)患者中的23例(74%)以及57例急性髓系白血病(AML)患者中的53例(93%)中检测到了wt1转录本。此外,慢性粒细胞白血病(CML)患者的单核细胞仅在诊断为急变期时表达wt1基因。与人类急性白血病相反,反应性骨髓(n = 4)、健康志愿者外周血(n = 20)的单核细胞以及正常外周血CD34+造血祖细胞(n = 6)在可检测水平上均不表达wt1基因。在单细胞水平上使用抗WT1单克隆抗体6F-H2进行免疫荧光分析,我们发现翻译后的WT1蛋白仅存在于白血病原始细胞核中,而不存在于正常CD34+造血祖细胞核中。20例白血病患者中的12例(60%)通过RT-PCR检测wt1基因表达均呈阳性,其原始细胞显示出强烈的核免疫荧光。wt1基因在大多数人类急性白血病中表达,但在正常单核血细胞和正常CD34+造血祖细胞中不表达,这使得wt1基因转录本成为一种“泛急性白血病”标志物,可能有助于监测化疗后的微小残留病以及在检测用于自体骨髓移植的净化或未净化造血干细胞制剂中的白血病原始细胞。

相似文献

1
Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.多数人类急性白血病中存在威尔姆斯瘤基因(wt1)转录本和WT1核蛋白。
Leukemia. 1995 Jun;9(6):1060-7.
2
[Expression of Wilms' tumor gene (WT1) in leukemias and its clinical implication].[肾母细胞瘤基因(WT1)在白血病中的表达及其临床意义]
Zhonghua Xue Ye Xue Za Zhi. 1998 Jan;19(1):16-9.
3
Expression of the Wilms' tumor gene (WT1) in human leukemias.威尔姆斯瘤基因(WT1)在人类白血病中的表达。
Leukemia. 1992 May;6(5):405-9.
4
High expression of two diverged homeobox genes, HB24 and HB9, in acute leukemias: molecular markers of hematopoietic cell immaturity.两个分化的同源框基因HB24和HB9在急性白血病中的高表达:造血细胞不成熟的分子标志物
Leukemia. 1993 Mar;7(3):446-51.
5
Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.HOXA10 同源框基因在正常和白血病造血细胞中的阶段及谱系特异性表达。
Exp Hematol. 1995 Oct;23(11):1160-6.
6
Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells.候选威尔姆斯瘤基因WT1在人白血病细胞中的表达。
Leukemia. 1993 Jul;7(7):970-7.
7
Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.Wilms 瘤基因 1 蛋白抑制人造血祖细胞和白血病细胞中肿瘤抑制因子干扰素调节因子 8 的表达。
Leukemia. 2010 May;24(5):992-1000. doi: 10.1038/leu.2010.33. Epub 2010 Mar 18.
8
Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis.威尔姆斯瘤基因(WT1)在正常造血过程中的表达。
Exp Hematol. 1997 Apr;25(4):312-20.
9
WT1 protein expression in childhood acute leukemia.WT1蛋白在儿童急性白血病中的表达
Am J Hematol. 2008 May;83(5):382-6. doi: 10.1002/ajh.21123.
10
The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells.威尔姆斯瘤基因在急性髓细胞白血病中的表达作为白血病原始细胞的一种可能标志物。
Leukemia. 1994 Dec;8(12):2138-43.

引用本文的文献

1
Predicting antigen-specific T-cell immunity against Wilms tumor 1 in hematologic cancer.预测血液系统癌症中针对威尔姆斯瘤1的抗原特异性T细胞免疫。
Leukemia. 2025 Aug 22. doi: 10.1038/s41375-025-02727-y.
2
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence.一项针对急性髓系白血病患者和异基因造血细胞移植后活动性疾病患者的WT1特异性TCR基因治疗I/II期试验:向NK样表型倾斜会损害T细胞功能和持久性。
Nat Commun. 2025 Jun 5;16(1):5214. doi: 10.1038/s41467-025-60394-0.
3
Precision Medicine in Myeloid Neoplasia: Challenges and Opportunities.
骨髓增殖性肿瘤中的精准医学:挑战与机遇
J Pers Med. 2025 Jan 26;15(2):49. doi: 10.3390/jpm15020049.
4
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and Persistence.急性髓系白血病使治疗性WT1特异性CD8 T细胞受体T细胞向自然杀伤细胞样表型转变,从而损害其功能和持久性。
medRxiv. 2024 Dec 16:2024.12.13.24318504. doi: 10.1101/2024.12.13.24318504.
5
REGAL: galinpepimut-S vs. best available therapy as maintenance therapy for acute myeloid leukemia in second remission.REGAL研究:galinpepimut-S与最佳可用疗法作为急性髓系白血病第二次缓解期维持治疗的比较。
Future Oncol. 2025 Jan;21(1):73-81. doi: 10.1080/14796694.2024.2433935. Epub 2024 Nov 28.
6
Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia.通过三种不同方法进行可测量残留疾病研究,可以预测儿童急性髓细胞白血病的复发并指导抢先治疗。
Clin Transl Oncol. 2023 May;25(5):1446-1454. doi: 10.1007/s12094-022-03042-z. Epub 2023 Jan 4.
7
The Role of Wilms' Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia.肾母细胞瘤基因(WT1)表达作为急性髓系白血病微小残留病标志物的作用
J Clin Med. 2022 Jun 9;11(12):3306. doi: 10.3390/jcm11123306.
8
Genetic and Epigenetic Signatures in Acute Promyelocytic Leukemia Treatment and Molecular Remission.急性早幼粒细胞白血病治疗及分子缓解中的遗传和表观遗传特征
Front Genet. 2022 Apr 12;13:821676. doi: 10.3389/fgene.2022.821676. eCollection 2022.
9
First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience.在缓解期老年 AML 患者中进行 WT1 重组蛋白疫苗接种的首次人体研究:单中心经验。
Cancer Immunol Immunother. 2022 Dec;71(12):2913-2928. doi: 10.1007/s00262-022-03202-8. Epub 2022 Apr 27.
10
Mouse Models of Frequently Mutated Genes in Acute Myeloid Leukemia.急性髓系白血病中常见突变基因的小鼠模型
Cancers (Basel). 2021 Dec 8;13(24):6192. doi: 10.3390/cancers13246192.